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Introduction 
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a 
vital role in the post-transcriptional regulation of gene expression. 
Deregulated miRNA expression is a prominent feature in acute myeloid
leukemia (AML) – an hematologic malignancy with a particularly high
rate of mortality.
Purpose
Identifying the involvement of miRNAs in AML(Figure 1) to
determine pathogenicity, early diagnosis and potential miRNA-based
therapeutic strategies.
Material and methods
The bibliographic analysis of the scientific literature regarding the involvement of 
miRNA through various mechanisms in AML, published in the last 10 years, was
performed using the search portals: PubMed, HINARI and MedScape.
Results
The most common mechanisms by which miRNA expression becomes
differentiated in AML are epigenetic and targeting changes with dregregated
transcription factors or oncogenic fusion proteins. The existence of distinct miRNA
profiles in different AML subtypes indicates that they have contributed to the
heterogeneity of AML and requires potential inclusion in the clinical diagnostic 
strategy. Approximately 100 aberrant miRNAs were identified in AML (Table 1). 
Changes in miRNA expression levels can increase the body's sensitivity to
chemotherapy or other drugs.
Conclusions
(1) miRNA expression profile is aberrant in AML and hold a diagnostic and
prognostic relevance (2) With in-depth studies, further clarifying the expression, 
function and regulatory mechanism of miRNAs will provide promising strategies for 
AML treatment.
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THE ROLE OF miRNA IN ACUTE MYELOID LEUKEMIA
Figure 1. Schematic diagram of microRNAs role in AML.
Table 1. miRNAs that are involved in the pathogenesis of AML
Subtype Genetic subtype Up-regulated miRNA Down-regulated miRNA
AML (15; 17) miR-127, miR-134, miR-299-







AML t (8; 21) miR-27a, miR-126, miR-150, miR 
-223, miR-29b-3p
miR-126-5p
